stockrow
Friday 6 November 2026
Export VXRT’s income statement to Excel — free account
VAXART, INC.
VXRT Healthcare Biotechnology
VAXART, INC.’s revenue for fiscal 2025 (year ended December 2025) was $237.3 million, up 726.7% from fiscal 2024.
- Revenue
- −85.3%
- EPS
- −75.0%
- Free cash flow
- −57.2%
Quarter to September 2026, against a year earlier
0.37
0.03
−7.50%
Follow VXRT
Alert me
VAXART, INC. (VXRT) P/E ratio
As of 5 November 2026, VAXART, INC. (VXRT) trades at a P/E ratio of 2.8×. Over the past ten years it has ranged from 0.0× (December 2025) to 35.6× (January 2015); the current reading is higher than 87% of that period. That is below the Biotechnology industry median of 10.3× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 5.8× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2017 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 3.5× | (9.21%) |
| Jun 2026 | 3.8× | (6.25%) |
| Mar 2026 | 4.1× | (30.28%) |
| Dec 2025 | 5.8× | — |
| 39 more quarters | Free account |
Against its own ten years
Low 0.0×
High 35.6×
Ten-year median
0.0×
Current reading's percentile
87
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CBUS Cibus, Inc. compare | n/m |
| EQ Equillium, Inc. compare | n/m |
| PLYX Polaryx Therapeutics, Inc. compare | n/m |
| SEER Seer, Inc. compare | n/m |
| VTVT vTv Therapeutics Inc. compare | n/m |
| MIST Milestone Pharmaceuticals Inc. compare | n/m |
| KZIA Novogen Limited compare | n/m |
| VXRT VAXART, INC. | 2.8× |
| ICCC ImmuCell Corporation compare | 117× |
| Biotechnology industry median | 10.3× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)